1-(3-Chloro-phen-yl)-5-(2,4-di-hydroxy-benzo-yl)pyridin-2(1H)-one.

Acta Crystallogr Sect E Struct Rep Online

The First Affiliated Hospital of Xinxiang Medical University, Weihui 453100, Henan Province, People's Republic of China.

Published: May 2013

The chloro-phenyl group of the title compound, C18H12ClNO4, is disordered over two orientations with occupancies of 0.331 (8) and 0.669 (8). An intra-molecular hydrogen bond is formed between a hy-droxy group and the acyclic carbonyl group. In the crystal, molecules are linked into chains along [110] by O-H⋯O and C-H⋯O hydrogen bonds, forming a ladder motif.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648264PMC
http://dx.doi.org/10.1107/S1600536813009689DOI Listing

Publication Analysis

Top Keywords

1-3-chloro-phen-yl-5-24-di-hydroxy-benzo-ylpyridin-21h-one chloro-phenyl
4
chloro-phenyl group
4
group title
4
title compound
4
compound c18h12clno4
4
c18h12clno4 disordered
4
disordered orientations
4
orientations occupancies
4
occupancies 0331 8
4
0331 8 0669 8
4

Similar Publications

The crystal structure of luliconazole {LCZ; CHClNS; systematic name: ()-[(4)-4-(2,4-di-chloro-phen-yl)-1,3-di-thio-lan-2-yl-idene](1-imidazol-1-yl)aceto-nitrile} is reported. In the mol-ecule of the title compound, the di-thiol-ane ring adopts an envelope conformation, while the di-chloro-phenyl ring exhibits disorder. In the crystal packing of luliconazole, only two inter-molecular C-H⋯N hydrogen bonds are observed.

View Article and Find Full Text PDF

Synergistic effect of the sphingosine kinase inhibitor safingol in combination with 2'-nitroflavone in breast cancer.

J Mol Med (Berl)

December 2024

Laboratorio de Oncología y Transducción de Señales, Instituto de Química y Fisicoquímica Biológicas (IQUIFIB), Departamento de Química Biológica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, CONICET, Junin 956, C1113AAD, Buenos Aires, Argentina.

Article Synopsis
  • Sphingosine kinase-1 (SPHK1) is often elevated in breast cancer and promotes various cancer-related processes, making it a target for new treatments.
  • The synthetic flavonoid 2'-nitroflavone (2'NF) shows strong anti-cancer effects, especially when combined with SPHK inhibitors like safingol.
  • In both cell lines and animal models, the combination of safingol and 2'NF demonstrated a synergistic effect that enhances tumor cell death without harming normal tissues, suggesting a promising approach for HER2-positive breast cancer therapy.
View Article and Find Full Text PDF

Background: The abuse of psychoactive substances presents challenges in clinical and forensic toxicology. The emergence of novel and potent drugs that pose significant health risks, in particular towards frequent abusers and users unaware of the ingredients, further complicates the situation. Designer benzodiazepines have become a fast-growing subgroup of these new psychoactive substances (NPSs), and their overdose may potentially turn fatal, especially when combined with other central nervous system depressants.

View Article and Find Full Text PDF

Biosafety assessment of novel organoselenium zidovudine derivatives in the Caenorhabditis elegans model.

Toxicol Appl Pharmacol

October 2024

Federal University of Santa Maria, Center for Natural and Exact Sciences, Department of Biochemistry and Molecular Biology, Postgraduate Program in Biological Sciences: Toxicological Biochemistry, Camobi, Zip code 97105-900 Santa Maria, RS, Brazil. Electronic address:

Antiretrovirals have improved considerably since the introduction of 3'-azido-3'-deoxythymidine (zidovudine or AZT), a molecule with also anticancer effects. Subsequently, a variety of other nucleosides have been synthesized. However, these medications are often associated with serious adverse events and the onset or exacerbation of degenerative processes, diseases, and syndromes, affecting mainly the mitochondria.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!